Current Concept of Stem Cell Therapy for Spinal Cord Injury

Major Points and Findings:

1. Introduction and Background:

• Spinal cord injury (SCI) is a devastating condition that can lead to significant neurological deficits. The incidence of SCI is approximately 29.5 cases per million per year, with over a million patients suffering from paralysis due to SCI.
• The primary causes of SCI include motor vehicle accidents, falls, violence, sports injuries, and industry-related injuries. Most patients affected are young men, particularly those aged 20 to 29.
• Despite various treatments available, such as medication, surgery, and rehabilitation, there is no definitive treatment for chronic SCI.

2. Pathophysiology of SCI:

• SCI can be classified into primary and secondary injuries. Primary injuries result from external forces like compression or contusion, while secondary injuries are a series of reactions triggered by the primary injury. These reactions can include inflammation, decreased blood flow, and cell apoptosis.

3. Stem Cell Therapy:

• Stem cells have the potential to differentiate into various cell types and secrete substances like cytokines and growth factors that promote neuroprotection.
• Different types of stem cells have been considered for therapy, including embryonic stem cells, adult stem cells, Schwann cells, olfactory ensheathing cells (OEC), and bone marrow-derived mesenchymal stem cells (BM MSCs).

4. Bone Marrow Derived Mesenchymal Stem Cells (BM MSCs):

• BM MSCs are multipotent progenitor cells that can differentiate into neural cells and have anti-inflammatory properties.
• These cells can be harvested from the patient’s bone marrow, avoiding ethical issues or rejection complications.
• Clinical studies using BM MSCs have shown promise. For instance, a study by Park et al. reported that six out of ten patients showed motor improvement in the upper extremities after BM MSCs transplantation.

5. Strategies for Optimizing Stem Cell Therapy:

• The route of administration is crucial for the efficacy of stem cell therapy. Options include intravenous, intrathecal, and direct intramedullary injections.
• Direct injection into the injured site is considered the most effective method for chronic SCI, despite potential risks.

6. Conclusion:

Stem cell therapy offers a promising avenue for SCI treatment. Despite challenges, it opens new perspectives for addressing this debilitating condition.